SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KM who wrote (768)8/25/1999 3:49:00 PM
From: Cheeseburger  Read Replies (1) of 900
 
Hey KM, you knucklehead. Sept. 16th is the day the FDA's panel of experts -- ODAC -- convene in some Maryland Hillbilly Hotel to review Evacet data presented by Liposome and the FDA. After hearing both sides, the panel will vote on whether the FDA should or should not clear Evacet for marketing -- the vote usually happens by 3:30 p.m. The FDA isn't bound to its panel's recommendations, but it usually follows its direction. Either way, the approval (or rejection) will take at least six weeks from Sept. 16th.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News